Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?

Hasan M. Shihab, Fred Lutwama, Theresa Piloya, Barbara Castelnuovo, Andrew D. Kambugu, Robert Colebunders

Research output: Contribution to journalArticle

Abstract

A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edema.

Original languageEnglish (US)
Pages (from-to)405-407
Number of pages3
JournalJournal of infection in developing countries
Volume3
Issue number5
DOIs
StatePublished - 2009

Keywords

  • Edema
  • Lopinavir/Ritonavir
  • Resource-limited setting

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Infectious Diseases
  • Virology

Fingerprint Dive into the research topics of 'Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?'. Together they form a unique fingerprint.

  • Cite this